CVET News and Press, Covetrus Inc.

Covetrus® , a global leader in animal-health technology and services, today announced the appointment of Ajoy Karna as executive vice president and chief financial officer. Karna succeeds Matthew Foulston, who announced previously his retirement from the company. This press release fea...

Westlake Set to Join S&P MidCap 400; MillerKnoll to Join S&P SmallCap 600 Westlake Set to Join S&P MidCap 400; MillerKnoll to Join S&P SmallCap 600 PR Newswire NEW YORK , Oct. 13, 2022 /PRNewswire/ -- Westlake Corp. (NYSE:WLK) will rep...

NEW YORK, NY / ACCESSWIRE / September 28, 2022 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Covetrus, Inc. (NASDAQ:CVET)'s ...

Covetrus ® (NASDAQ: CVET), a global leader in animal-health technology and services, today announced the appointment of Michelle Bonfilio as Chief People Officer, reporting to Ben Wolin, President and Chief Executive Officer at Covetrus. In this role, Bonfilio will oversee ...

Summary Silver Ring Value Partners provides investment advisory services. The Company offers portfolio management, financial planning, and trading services. Silver Ring Value Partners serves investors in the State of Massachusetts. At the end of June 2022 the portfolio was very at...

Matthew Foulston, EVP and CFO at Covetrus ( NASDAQ: CVET ), has announced plans to retire from the firm effective December 31, 2022. A search for the role of CFO is underway, and Foulston is assisting in the process to ensure a smooth transition to his successor. For...

Covetrus ® (NASDAQ: CVET), a global leader in animal-health technology and services, today announced that Matthew Foulston, the Company’s Executive Vice President and Chief Financial Officer, has informed the company that he will be retiring from the company effective De...

Covetrus press release ( NASDAQ: CVET ): Q2 GAAP EPS of -$0.03 misses by $0.06 . Revenue of $1.22B (+2.5% Y/Y) in-line. Non-GAAP organic net sales growth of 5% year-over-year Non-GAAP adjusted EBITDA was flat year-over-year at $66 million, including a $2 millio...

Second quarter 2022 net sales of $1.22 billion, an increase of 2% year-over-year; GAAP net loss attributable to Covetrus of $(4) million Non-GAAP organic net sales growth of 5% year-over-year Non-GAAP adjusted EBITDA was flat year-over-year at $66 million, including ...

Covetrus ( NASDAQ: CVET ) is scheduled to announce Q2 earnings results on Thursday, August 4th, before market open. The consensus EPS Estimate is $0.25 (+208.7% Y/Y) and the consensus Revenue Estimate is $1.22B (+2.5% Y/Y). Over the last 1 year, CVET has beaten EPS e...